{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:11:49Z","timestamp":1760145109861,"version":"build-2065373602"},"reference-count":29,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated disorder presenting as mass-like lesions with obstructions. An elevated serum IgG4 level is identified in more than half of affected patients and is considered a diagnostic criterion. IgG4-RD is still easily misdiagnosed as neoplastic or infectious disease. We aimed to conduct a hospital-based study to illuminate the association between serum IgG4 levels and pancreatobiliary disorders and cancer. Methods: In this study, serum IgG4 levels were assessed at our hospital\u2019s immunology laboratory, utilizing data from the hospital\u2019s computer center, and the diagnostic codes used were based on ICD-9-CM. We analyzed IgG4 level data collected between April 2013 and April 2020, including patients\u2019 age, gender, and diseases, but excluding the rationale for IgG4 level assessment. Employing propensity score matching (PSM) at a 1:1 ratio to mitigate age and gender confounding, we analyzed 759 patients divided into groups by IgG4 levels (\u2264140 and &gt;140 mg\/dL; and \u2264140, 141\u2013280, &gt;280 mg\/dL). We explored associations between IgG4 levels and conditions such as pancreatobiliary cancer (the group included cholangiocarcinoma, pancreatic cancer, and ampullary cancer), cholangitis, cholangiocarcinoma, pancreatitis, pancreatic cancer, and ampullary cancer. Results: Our study analyzed the demographics, characteristics, and serum IgG4 levels of participants and found no significant differences in serum IgG4 levels across various pancreatobiliary conditions. Nevertheless, the crude odds ratios (ORs) suggested a nuanced association between a higher IgG4 level &gt; 280 mg\/dL and increased risks of cancer and pancreatitis, with crude ORs of 1.52 (p = 0.03) and 1.49 (p = 0.008), respectively. After PSM matching, the further analysis of 759 matched patients showed no significant differences in IgG4 levels &gt; 140 mg\/dL between cancerous and non-cancerous groups, nor across other pancreatobiliary conditions. A higher serum IgG4 level &gt; 280 mg\/dL was significantly associated with pancreatobiliary cancer and cholangiocarcinoma, with crude ORs of 1.61 (p = 0.026) and 1.62 (p = 0.044), respectively. In addition, IgG4 &gt; 280 mg\/dL showed a greater association with pancreatic cancer compared with 141\u2013280 mg\/dL, with crude OR of 2.18 (p = 0.038). Conclusions: Our study did not find a clear association between serum IgG4 levels (&gt;140 mg\/dL) and pancreatobiliary cancer. We observed that higher IgG4 levels (&gt;280 mg\/dL) may be associated with cholangiocarcinoma and pancreatic cancer, as indicated by crude ORs. However, the adjusted analysis did not demonstrate the significant association between IgG4 level &gt; 280 mg\/dL and cancer. Considering IgG4-RD as a chronic and persistent inflammatory status, it is more closely associated with inflammatory diseases than with cancer. Therefore, further long-term cohort studies are necessary to evaluate the potential role of IgG4 levels in cancer risk among these patients.<\/jats:p>","DOI":"10.3390\/jcm13133651","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T06:59:58Z","timestamp":1719212398000},"page":"3651","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Implications of Serum IgG4 Levels for Pancreatobiliary Disorders and Cancer"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7159-4670","authenticated-orcid":false,"given":"Ching-Tang","family":"Tseng","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 407, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Jun","family":"Liao","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 407, Taiwan"},{"name":"Department of Post-Baccalaureate Medicine, School of Medicine, National Chung Hsing University, Taichung 402, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Li","family":"Lin","sequence":"additional","affiliation":[{"name":"Management Office for Health Data, Clinical Trial Center (CTC), China Medical University Hospital, Taichung 404, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Chun","family":"Peng","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 407, Taiwan"},{"name":"Department of Post-Baccalaureate Medicine, School of Medicine, National Chung Hsing University, Taichung 402, Taiwan"},{"name":"School of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imr.12349","article-title":"Human IgG4: A structural perspective","volume":"268","author":"Davies","year":"2015","journal-title":"Immunol. Rev."},{"key":"ref_2","first-page":"638","article-title":"Review of IgG4-related disease","volume":"42","year":"2019","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_3","first-page":"m1067","article-title":"Advances in the diagnosis and management of IgG4 related disease","volume":"369","author":"Lanzillotta","year":"2020","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"iii123","DOI":"10.1093\/rheumatology\/kez667","article-title":"IgG4-related disease: A clinical perspective","volume":"59","author":"Maritati","year":"2020","journal-title":"Rheumatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: An update on pathophysiology and implications for clinical care. Nature reviews","volume":"16","author":"Perugino","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_7","first-page":"115","article-title":"IgG4-Related Disease and Innate Immunity","volume":"401","author":"Watanabe","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: Back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: Triggers, Mechanisms, and Consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.5761\/atcs.cr.12.02208","article-title":"Lung cancer complicated with IgG4-related disease of the lung","volume":"20","author":"Inoue","year":"2014","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.17116\/patol201678443-47","article-title":"Gastric cancer concurrent with IgG4-related disease: A clinical case and a review of literature","volume":"78","author":"Kazantseva","year":"2016","journal-title":"Arkh. Patol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/art.39773","article-title":"Association of IgG4-Related Disease With History of Malignancy","volume":"68","author":"Wallace","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_14","first-page":"524","article-title":"IgG4-related sclerosing cholangitis may be a risk factor for cancer","volume":"28","author":"Kurita","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e000661","DOI":"10.1136\/jitc-2020-000661","article-title":"An immune evasion mechanism with IgG4 playing an essential role in cancer and implication for immunotherapy","volume":"8","author":"Wang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","article-title":"Risk of malignancies in IgG4-related disease","volume":"22","author":"Yamamoto","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/RHU.0000000000001244","article-title":"IgG4-Related Disease Misdiagnosed as Neoplasm","volume":"27","author":"Dzhus","year":"2021","journal-title":"J. Clin. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00534-006-1152-y","article-title":"Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines","volume":"14","author":"Kimura","year":"2007","journal-title":"J. Hepatobiliary Pancreat. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00534-012-0561-3","article-title":"TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos)","volume":"20","author":"Kiriyama","year":"2013","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jhbp.515","article-title":"Tokyo Guidelines 2018: Diagnostic criteria and severity grading of acute cholecystitis (with videos)","volume":"25","author":"Yokoe","year":"2018","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis--2012: Revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"Banks","year":"2013","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/gut.2012.201201gt","article-title":"Chronic pancreatitis","volume":"61","author":"Garg","year":"2012","journal-title":"Gut"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pan.2013.05.002","article-title":"Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: Recommendations from PancreasFest 2012","volume":"13","author":"Rickels","year":"2013","journal-title":"Pancreatology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: Guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1155\/2013\/180461","article-title":"Immunoglobulin G4-related pancreatic and biliary diseases","volume":"27","author":"Barkun","year":"2013","journal-title":"Can. J. Gastroenterol. Hapatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/2050640620924302","article-title":"Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency","volume":"8","author":"Barresi","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11882-015-0580-7","article-title":"IgG4 Characteristics and Functions in Cancer Immunity","volume":"16","author":"Crescioli","year":"2016","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00428-017-2286-9","article-title":"Lymphomas in IgG4-related disease: Clinicopathologic features in a Western population","volume":"472","author":"Bledsoe","year":"2018","journal-title":"Virchows Arch."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PAI.0000000000000462","article-title":"IgG4 Expression in Primary Cutaneous Marginal Zone Lymphoma: A Multicenter Study","volume":"26","author":"Ferry","year":"2018","journal-title":"Appl. Immunohistochem. Mol. Morphol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/13\/3651\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:02:57Z","timestamp":1760108577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/13\/3651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,22]]},"references-count":29,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["jcm13133651"],"URL":"https:\/\/doi.org\/10.3390\/jcm13133651","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2024,6,22]]}}}